by John Conrad | Aug 20, 2024 | NewsBrief
According to PitchBook’s latest Emerging Tech Research report on the medtech industry, the sector is showing resilience and growth despite recent market challenges. The report highlights the successful IPO of precision medicine company Tempus in June 2024 as a...
by John Conrad | Aug 16, 2024 | iBIO News
NewsBrief Weekly News Quiz: August 16th Friday Biotech Blitz: Challenge Your Scientific Acumen 🧬🔬 Calling all biotech buffs! Our weekly iBIO NewsBrief Quiz is here to test your grasp of the latest breakthroughs. This week’s lineup: 5 cutting-edge...
by John Conrad | Aug 15, 2024 | Policy News
Endpoints News reported that the Biden administration has unveiled projections for the Inflation Reduction Act’s (IRA) impact on drug pricing. According to the announcement, IRA negotiations are anticipated to generate $6 billion in taxpayer savings by 2026,...
by John Conrad | Aug 14, 2024 | Policy News
In a bold move to secure Illinois’ economic future, Governor JB Pritzker has unveiled a comprehensive five-year economic growth plan that places a strong emphasis on the life sciences sector. This strategic focus aims to position Illinois at the forefront of...
by John Conrad | Aug 13, 2024 | NewsBrief
In a significant move that reshapes the landscape of the medical technology industry, Baxter International Inc. has announced a definitive agreement to sell its Kidney Care segment, soon to be renamed Vantive, to global investment firm Carlyle for $3.8 billion. This...
